Results

Total Results: 446 records

Showing results for "drug".

81. SNAC Member: Yanling Yu, Ph.D. | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/cpi/about/nac/snac-yu.html
    December 01, 2021 - Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee. Dr.

82. Selected Best Practices and Suggestions for Improvement (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/d4n_combo_iqi-mortalityreview-bestpractices.pdf
    May 20, 2016 - within 30 days ∗ Return to emergency department within 3 days of discharge ∗ Death associated with drug … reaction ∗ Death associated with adverse drug reaction ∗ Death associated with medication error … within 30 days ∗ Return to emergency department within 3 days of discharge ∗ Death associated with drug … reaction ∗ Death associated with adverse drug event ∗ Death related to medical device ∗ Healthcare-associated

83. CAHPS Cancer Care Survey | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/cahps/surveys-guidance/cancer/index.html
    July 01, 2020 - Survey 5.0 (ZIP, 4 MB)   The ZIP file includes: Three survey instruments (for Radiation Therapy, Drug … survey instruments and recommended administration methods: Radiation Therapy Survey (PDF, 241 KB) Drug

84. Aspirin Use Evidence and Resources | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/evidencenow/projects/heart-health/evidence/aspirin.html
    March 01, 2021 - with a history of a heart attack, and patients with a history of a stroke who use aspirin or a similar drug … have at least 70 percent of patients for whom aspirin use is recommended be taking it or a similar drug

85. HHS AHRQ Freedom of Information Annual Report - FY 2010 | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/policy/foia/foiafy10.html
    November 01, 2020 - www.cdc.gov/od/foia Centers for Medicare & Medicaid Services (CMS): http://www.cms.hhs.gov/foia Food and Drug … Officer 1600 Clifton Road, N.E., MS D-54 Atlanta, Georgia 30333 Phone: 404-498-1580 Food and Drug … Toxic Substances and Disease Registry CDC—Centers for Disease Control and Prevention FDA—Food and Drug … for Disease Control and Prevention CMS - Centers for Medicare & Medicaid Services FDA - Food and Drug

86. Section 1, Tables 1 to 3 (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-216-scd-fever-section-1-tables-1-3.pdf
    February 20, 2018 - sickle cell anemia) Hb F,S 282.6, 282.61, 282.62 Table 2: Parenteral broad‐spectrum antibiotics Drug

87. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004 ix … Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf. 2009;32(11):1089-1110 xi Gould MS, Walsh BT, Munfakh JL, et al.

88. Section 2, Technical Specifications (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-tech-specs.pdf
    June 15, 2018 - hypotension) < 5th percentile for age or systolic BP < 2 SD below normal for age OR • Need for vasoactive drug

89. Table 5. Evidence Supporting Emergency Department Pain Assessment for Children With Sickle Cell Disease (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-section-5-table-5.pdf
    April 01, 2014 - Most patients with acute pain are neither drug addicts nor seekers.

90. Value Set Export (xls file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085behaviorcoding.xls
    January 01, 2012 - FFS PHDSC 2.16.840.1.113883.221.5 Payer Individual Characteristic Source of Payment Typology 4.0 122 Drug … Improvement(R) (AMA-PCPI) 2.16.840.1.113883.3.526.3.1363 Illicit, Prescription and Over the Counter Drug … /Assessment GROUPING n/a 2.16.840.1.113883.3.526.2.1445 "Illicit, Prescription and Over the Counter Drug … Improvement(R) (AMA-PCPI) 2.16.840.1.113883.3.526.2.1445 Illicit, Prescription and Over the Counter Drug … Use Screening Risk Category/Assessment LOINC 2.38 68526-3 Do you abuse more than one drug at a time

91. Synthetic Healthcare Database for Research (SyH-DR) | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/data/innovations/syh-dr.html
    January 01, 2024 - The database consists of a sample of inpatient, outpatient, and prescription drug claims, including utilization … , 212 KB) Primary Diagnosis (DX) Imputed Flag, January 2024 (PDF, 231 KB) Removal of Synthetic Drug

92. AHRQ News Now | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/news/newsletters/e-newsletter/index.html
    April 23, 2024 - Developers and Users of Digital Healthcare Technologies Advance Equity April 9, 2024 Surge in Drug … Contribute to Diagnostic Errors May 2, 2023 Medication Reconciliation Intervention Reduces Drug

93. AHRQ News Now | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2
    April 05, 2022 - Views Blog: Healthcare, Climate Change, Environmental Justice and AHRQ October 5, 2021 Drug … Label Changes Could Reduce Adverse Drug Reactions Among Older Adults September 29, 2021

94. Helping to Answer Pressing Policy Questions with Data and Analytics | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/news/blog/ahrqviews/answer-policy-questions-data.html
    March 01, 2021 - decisions on critical issues ranging from expanding access to health insurance to lowering prescription drug … ACA-related issues pertaining to coverage gaps, uneven subsidies, and premium assistance Prescription drug

95. Opioids AHRQ Works: Building Bridges Between Research and Practice (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/topics/impact-opioid-final.pdf
    November 01, 2018 - Opioids AHRQ Works: Building Bridges Between Research and Practice Opioids Deaths from drug

96. AHRQ National Scorecard on Hospital-Acquired Conditions: Final Results for 2014 Through 2017 (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/Updated-hacreportFInal2017data.pdf
    July 01, 2020 - 28 measures of patient safety events, including many types of hospital-acquired infections, adverse drug … For example, measured adverse drug events continued to drop from 2014 to 2017, while measured pressure … Central Line-Associated Bloodstream Infections Catheter-Associated Urinary Tract Infections Adverse Drug … of HACs 2017 Normalized Count of HACs Percent Change in HACs, 2014 vs. 2017 Adverse Drug … Measures used to estimate the national HAC rate HAC Type Source Measure Adverse Drug Event MPSMS

97. Adolescents who present to the ED with psychotic symptoms should receive the laboratory tests | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/pqmp/measures/adolescents-psychotic-symptoms.html
    August 01, 2021 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

98. Pediatric Patient Safety Consortium (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIII.pdf
    August 13, 2014 - Please provide documentation of the item's current classification by the Food and Drug Administration … Identify the Item (product or drug/biological) for which a Level II HCPCS Code is being requested. … A) Trade or Brand Name: B) General Product Name or Generic Drug Name (active ingredient): C) FDA … (If a drug - list other drugs by trade name marketed under the same active ingredient category/generic … For drugs and biologicals only: In order for an application for a code for a drug/biological can be

99. Pediatric Patient Safety Consortium (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA202-Materials_XIII.pdf
    January 01, 2014 - Please provide documentation of the item's current classification by the Food and Drug Administration … Identify the Item (product or drug/biological) for which a Level II HCPCS Code is being requested. … A) Trade or Brand Name: B) General Product Name or Generic Drug Name (active ingredient): C) FDA … (If a drug - list other drugs by trade name marketed under the same active ingredient category/generic … For drugs and biologicals only: In order for an application for a code for a drug/biological can be

100. Appendix | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/hai/pfp/hacrate2013-appendix.html
     October 01, 2015 - Measured HACs c Projected Cost Savings in 2013 d Projected Reductions in Deaths in 2013 e Adverse Drug … Goal for HAC Reduction b PfP HAC Reduction Goal c Estimated PfP Additional Cost* per HAC Adverse Drug … 2014 Goal Met Projected Reductions in Deaths Associated With HACs in 2014 if 2014 Goal Met Adverse Drug